Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 44Burkitt Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Mantle-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Smoldering Multiple Myeloma 3Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Immunoglobulin Light-chain Amyloidosis 3Brain Neoplasms 3Blast Crisis 3Plasmacytoma 2Neoplasms 2Leukemia, Plasma Cell 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Hematologic Neoplasms 2Breast Neoplasms 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Renal Insufficiency 1Recurrence 1Prostatic Neoplasms 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1POEMS Syndrome 1Ovarian Neoplasms 1

Interventions

Dexamethasone 8Bortezomib 7Cyclophosphamide 6Lenalidomide 4isatuximab 3glucarpidase 3Calcium Dobesilate 3Thalidomide 2Kidney Transplantation 2Blood Specimen Collection 2Bendamustine Hydrochloride 2pomalidomide 1gamma-Glutamyl Hydrolase 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Whole-Body Irradiation 1Urination 1Urinalysis 1Stents 1Standard of Care 1Rituximab 1Ranitidine 1Nephrotomy 1Nephrostomy, Percutaneous 1Methotrexate 1Leucovorin 1Ice 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Renal Insufficiency × auricularum × Clear all
NCT04352205 2024-07-01

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Emory University

Phase 2 Terminated
17 enrolled
Plasma cell

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡